Hay Fever
📧 Sign up to get email alerts when something new happens for Hay Fever.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis. [Phase 4]
Phase 4 trial update investigating methylprednisolone injections for birch pollen–induced allergic rhinitis (hay fever).
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray [Phase 3]
Phase 3 trial updating demonstration of equivalence and early onset for a novel anti-allergic nasal spray compared to a marketed spray; stud…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-arm) [Phase 2]
This Phase 2, five-arm PK/PD and steady-state efficacy trial evaluated bilastine versus placebo in seasonal allergic rhinitis with rhinoconj…
-
CLINICAL_TRIALS trial_result · 2018-10-30Clinical Trial Update: Clinical Efficacy and Safety of Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis [Phase 3]
Phase 3 clinical trial evaluating subcutaneous immunotherapy with gpASIT+ for grass pollen-induced allergic rhinoconjunctivitis shows ongoin…
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis [Phase 3]
Phase 3 trial evaluating subcutaneous immunotherapy gpASIT+ for grass pollen-induced allergic rhinoconjunctivitis completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-19Clinical Trial Update: Observational Study With PASCALLERG ® in Patients With Hay Fever
An observational study of PASCALLERG in hay fever patients has completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR) [Phase 4]
Phase 4 randomized, double-blind, parallel-group, placebo-controlled trial evaluating cetirizine HCl syrup and loratadine syrup against plac…
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409) [Phase 3]
Phase 3 safety study evaluating the combination of ciclesonide nasal spray with inhaled fluticasone propionate/salmeterol in adults with per…
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405) [Phase 3]
A Phase 3 trial evaluating the safety of three dose levels of ciclesonide nasal spray for perennial allergic rhinitis in pediatric patients …
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401) [Phase 3]
A Phase 3 trial evaluating ciclesonide nasal spray for seasonal allergic rhinitis (hay fever) has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417) [Phase 3]
Phase 3 study assessing the safety and efficacy of ciclesonide in pediatric patients (6-11 years) with seasonal allergic rhinitis. The trial…
-
CLINICAL_TRIALS trial_result · 2016-09-01Clinical Trial Update: Study In Adults And Adolescents With Seasonal Allergic Rhinitis [Phase 3]
A Phase 3 clinical trial in adults and adolescents with seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS withdrawal · 2015-04-22Clinical Trial Update: Lactobacillus Acidophilus L92 on Markers of Allergic Inflammation by Nasal Provocation With Grass Pollen [Phase 3]
A Phase 3 trial evaluating Lactobacillus acidophilus L92 for markers of allergic inflammation in response to grass pollen for hay fever was …
-
CLINICAL_TRIALS trial_result · 2012-05-23Clinical Trial Update: Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR) [Phase 3]
Phase 3 clinical trial in adults and adolescents with seasonal allergic rhinitis (hay fever) completed; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2010-06-17Clinical Trial Update: Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen [Phase 1]
This Phase 1 trial assesses the safety, immunological effects, and potential efficacy of combining MPL adjuvant with a grass pollen allergen…